Literature DB >> 14389382

Acquired circulating anticoagulants in systemic collagen disease; auto-immune thromboplastin deficiency.

P G FRICK.   

Abstract

Entities:  

Keywords:  ANTICOAGULANTS; COLLAGEN DISEASES/blood in; LUPUS ERYTHEMATOSUS; THROMBOPLASTIC SUBSTANCES

Mesh：

Substances：

Year:  1955        PMID： 14389382

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  11 in total

1.  [Diaplacental transmission of auto-anti-bodies].

Authors:  A BEICKERT
Journal:  Klin Wochenschr       Date:  1961-03-01

2.  A disorder of blood coagulation in systemic lupus erythematosus.

Authors:  S L LEE; M SANDERS
Journal:  J Clin Invest       Date:  1955-12       Impact factor: 14.808

3.  Systemic lupus erythematosus.

Authors:  L C HILL
Journal:  Br Med J       Date:  1957-09-28

4.  Methods for detecting lupus anticoagulants and their relation to thrombosis and miscarriage in patients with systemic lupus erythematosus.

Authors:  D Ferro; M Saliola; C Quintarelli; G Valesini; S Basili; A M Grandilli; M S Bonavita; F Violi
Journal:  J Clin Pathol       Date:  1992-04       Impact factor: 3.411

5.  Phospholipid in the hexagonal II phase is immunogenic: evidence for immunorecognition of nonbilayer lipid phases in vivo.

Authors:  J Rauch; A S Janoff
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

6.  [Inhibitor of prothrombin activation].

Authors:  K Lechner; M Fischer; J Kühböck; C Steffen; W Waldhäusl
Journal:  Klin Wochenschr       Date:  1969-11-15

7.  Studies on an acquired inhibition of factor VIII induced by penicillin allergy.

Authors:  K G Klein; J D Parkin; F Madaras
Journal:  Clin Exp Immunol       Date:  1976-10       Impact factor: 4.330

8.  A new cryopathic syndrome.

Authors:  M Caudron; C Bieva; E Laurent; F De Meuter; W W Feremans; P Lebas; C L Malmendier
Journal:  J Clin Pathol       Date:  1980-09       Impact factor: 3.411

Review 9.  Laboratory Diagnosis of Antiphospholipid Syndrome: Insights and Hindrances.

Authors:  Arne Vandevelde; Katrien M J Devreese
Journal:  J Clin Med       Date:  2022-04-13       Impact factor: 4.964

10.  Correction by defects in clotting accelerator activity by administration of methionine and vitamin K and of a new sulfhydryl-substituted methylnaphthoquinone, vitamin K-S(II).

Authors:  J R CARTER; E D WARNER
Journal:  J Clin Invest       Date:  1958-01       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.